Biotech · Private company
Allysta Pharmaceutical
Track this companyFree. Adds Allysta Pharmaceutical to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- ALY688 Ophthalmic SolutionPhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- ALY688 0.1%Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ALY688 0.4%Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- H-1337 [1]Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- H-1337 [2]Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- H-1337 [3]Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- ALY688 Ophthalmic Solution in Subjects With Dry Eye DiseasePHASE2_PHASE3 · COMPLETED · started May 19, 2021ClinicalTrials.gov NCT04899518 · fetched Nov 12, 2026
- Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye DiseasePHASE1_PHASE2 · COMPLETED · started Dec 16, 2019ClinicalTrials.gov NCT04201574 · fetched Nov 12, 2026
- H-1337 Ophthalmic Solution Phase 1/2PHASE1_PHASE2 · COMPLETED · started Mar 15, 2018ClinicalTrials.gov NCT03452033 · fetched Nov 12, 2026